RNS Number : 0532S
Georgia Healthcare Group PLC
20 June 2018
London, 20 June 2018
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Enriko Beridze
|
|
2.
|
Reason for the notification
|
|
a)
|
Position / status
|
PDMR, General Director (CEO) at Gepha
|
|
b)
|
Initial notification / amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Georgia Healthcare Group PLC
|
|
b)
|
LEI:
|
213800RJGJDDZENQER80
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification Code
|
ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary shares
|
|
c)
|
Price(s) and volume(s)
|
|
Date
|
Price(s)
|
Volume(s)
|
|
15 June 2018
|
£2.67338
|
29,972
|
|
18 June 2018
|
£2.650
|
15,000
|
|
|
d)
|
Aggregated information
|
|
|
|
Aggregated volume
|
29,972 shares were purchased on 15 June 2018
15,000 shares were purchased on 18 June 2018
|
|
|
Aggregated price
|
15 June 2018: The aggregated volume price is £80,126.55
18 June 2018: The aggregated volume price is: £39,750
|
|
e)
|
Dates of the transaction
|
15 June 2018, 18 June 2018
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the
United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHLLFEERTIIFIT